Failings at Lilly Humalog plant catch FDA’s eye
February 26, 2010Manufacturing and Production Humalog, lilly
Eli Lilly has been sent a warning letter about a production facility in Puerto Rico, which says the company failed …
Zeltia continue strong growth
February 26, 2010Sales and Marketing 2009 financials, PharmaMar, Yondelis, Zeltia
Consolidated revenues at Spanish biopharmaceutical company Zeltia increased by 17% to 123.4 million euros enabling it to halve operating losses. …
Bayer pharma sales overcome European decline
February 26, 2010Sales and Marketing 2009 financials, Bayer, Xarelto
Bayer’s group sales dropped 5% to 31 billion euros in a “difficult year” for the company that saw a drop …
Talking Point: The future for pharmaceutical delivery
February 26, 2010Manufacturing and Production Polar Speed, Talking Point, logistics, supply chain, talking logistics
Will the future for pharmaceutical delivery need to become more exacting and regulated? An ever greater awareness of the need …
Quotient Clinical receives MHRA Supplementary Accreditation
February 26, 2010Research and Development Quotient
This is one of the highest levels of accreditation in Europe and confirms that Quotient Clinical is qualified to perform …
Government ups the ante in dementia research
February 26, 2010Research and Development Alzheimer's, dementia
The government has attempted to ‘up the ante’ in dementia research by convening a ministerial group comprising charities, scientists, research …
Nick Workman joins A La Carte
February 26, 2010Business Services A La Carte, appointment, business services
Life sciences recruitment search consultancy A La Carte has appointed Nick Workman as international director. In his new role he …
Olivia Wilmshurst-Smith joins Woolley Pau
February 26, 2010Medical Communications Woolley Pau, appointment, medical communications
Advertising agency Woolley Pau has appointed Olivia Wilmshurst-Smith as an account executive. She is a keen linguist and recently graduated …
GSK hits back at Avandia safety probe
February 25, 2010Sales and Marketing Avandia, diabetes
GlaxoSmithKline has hit back at allegations from US Senators that its diabetes drug Avandia raises the risk of heart attacks, …
Digital Pharma: Novartis tells cystic fibrosis stories
February 25, 2010Medical Communications Novartis, cystic fibrosis, digi, digi pharma, social media
Novartis has launched a new disease awareness campaign for cystic fibrosis that blurs the lines between fact and fiction. Its …
Avastin study in ovarian cancer meets primary endpoint
February 25, 2010Research and Development Cancer, avastin, ovarian
Preliminary results from a trial of Roche’s Avastin in advanced ovarian cancer suggest that the drug lengthens progression-free survival when …
Sanofi’s breast cancer candidate tipped for future success
February 25, 2010Research and Development, Sales and Marketing BSI-201, Sanofi-Aventis, breast cancer
A Sanofi-Aventis drug currently in phase III has been predicted as a future blockbuster in breast cancer treatment. Sanofi’s BSI-201 …
GSK’s Deidre Connelly named Woman of the Year
February 25, 2010Sales and Marketing GlaxoSmithKline, HBA, appointment, sales and marketing
The Healthcare Businesswomen’s Association has named Deidre Connelly its 2010 Woman of the Year. Connelly is president of North America …
CME Spotlight: Restoring confidence
February 25, 2010Medical Communications CME, CME Spotlight, Eugene Pozniak, ethics
As John Maynard Keynes said: “The long term doesn’t matter very much, because in the long run, we are all …
New starters at Double Helix
February 25, 2010Sales and Marketing Double Helix, appointment, sales and marketing
Healthcare consultancy Double Helix has appointed Amanda Siebols (pictured) as a research consultant and Ioanna Maraki as a research executive. …
Obama ‘closer than ever’ to health reform
February 25, 2010Sales and Marketing Obama, US healthcare
The continuing showdown over health insurance reform in the US reaches its next potential flashpoint today (Thursday) with what is …
Merck KGaA posts modest revenue increase
February 24, 20102009 financials, Erbitux, Merck KGaA, Merck Serono, Rebif
German pharma company Merck has posted a modest rise in revenue amidst strong pharma growth. Revenues increased 2.1% to 7.7 …
Sudler & Hennessey promotes Max Jackson
February 24, 2010Medical Communications Sudler & Hennessey, appointment, medical communications
Max Jackson has been promoted to chief executive, EMEA and APAC, at advertising agency Sudler & Hennessey (S&H). In his …
Avastin fails in phase III study
February 24, 2010Research and Development Roche, avastin, gastric cancer, stomach cancer
Roche’s Avastin does not help patients with a severe form of stomach cancer to live longer, according to the results …
NICE approves Yondelis
February 24, 2010Sales and Marketing NICE, PharmaMar, Yondelis
Cancer drug Yondelis has been approved by NICE for use on the NHS, but only after the manufacturer offered to …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
